ARCHIVES

FDA Describes Meeting With NCI In “Limited” Memo

This article is from The Cancer Letter archive.

Vol. 02 No. 19 | May 7, 1976

Download PDF Visit The Full Archive

Related Articles

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

Kimes Heads NCI Organ Systems Committee; Changes Being Implemented

April 1, 1988

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

September 23, 1983

Study Links Ovarian Cancer To Hormone Replacement

May 25, 2007

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003